EQUGLEV
LIVE

Serial Number

79301276

Owner

NOVARTIS AG

Filing Date

Nov 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EQUGLEV Trademark

Serial Number: 79301276 • Registration: 6422557

EQUGLEV is a trademark filed by NOVARTIS AG on November 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

SANDOZ AG (203 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

Trademark Details

Filing Date

November 9, 2020

Registration Date

July 20, 2021

Published for Opposition

May 4, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Nov 19, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Nov 19, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 3, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2021 CNSA
REFUSAL PROCESSED BY IB
Mar 29, 2021 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 10, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 10, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 10, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 10, 2021 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 5, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 5, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 2, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 1, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 15, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 11, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 9, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR